Home / Import refusals / F23-9340161-7/110002/1

FDA Import Refusal F23-9340161-7/110002/1 — AstraZeneca UK Ltd.

AstraZeneca UK Ltd. — FEI 3002850317

The FDA refused shipment F23-9340161-7/110002/1 from AstraZeneca UK Ltd. (United Kingdom) on September 3, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
September 3, 2025
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
75

Recent inspections

  • 1274179 (VAI Thu Apr 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1129231 (VAI Sun Feb 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1017549 (NAI Thu Apr 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 878183 (VAI Fri Apr 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 785250 (VAI Fri Mar 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • F23-9339962-1/80002/1 (Wed Sep 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7278562-1/11/1 (Thu May 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-8259678-2/11/1 (Thu Feb 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7048191-7/11/1 (Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-1470235-9/11/1 (Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources